by Katie Nightingale | Jul 12, 2022 | Myrovlytis Trust Blog
The 11th European Conference on Rare Diseases & Orphan Products 2022 was held from 27th June to 1st July. We were delighted to attend and present at this event focused on putting rare disease policy into action. Over 840 participants from 61 countries came...
by Katie Nightingale | May 9, 2022 | Myrovlytis Trust Blog
The Myrovlytis Trust is delighted to announce that registration and abstract submission for the virtual BHD Community Symposium 2022 is now open! Following the success of our research symposium in 2021, the Myrovlytis Trust and BHD Foundation are delighted to announce...
by Katie Nightingale | Feb 2, 2022 | Myrovlytis Trust Blog
The Myrovlytis Trust has been awarded the PIF TICK – the UK’s only quality mark for print and online health information. To become a ‘trusted information creator’, The Myrovlytis Trust had to undergo an assessment showing it met 10 key criteria. This means you can be...
by Katie Nightingale | Jan 18, 2022 | Myrovlytis Trust Blog
The Myrovlytis Trust is delighted to launch a call for proposals for our Spring 2022 round of funding. We are now open for applications for Small/Pilot Studies and PhD Studentships in our priority areas of Birt-Hogg-Dubé Syndrome (and related kidney disorders) and...
by Katie Nightingale | Dec 20, 2021 | Myrovlytis Trust Blog
The British Society for Immunology (BSI) Congress 2021 took place from 28 November to 1 December 2021 online and in-person in Edinburgh, UK. A primary aim of the Myrovlytis Trust is advancing research into immunotherapies and new routes to treatment for rare cancers,...
Recent Comments